OrbiMed raises $3B across two new life sciences funds
OrbiMed Advisors secured approximately $3 billion across two new healthcare venture funds, including over $1 billion dedicated to Asia investments, after backing several companies that recently went public or were acquired.
3 sourcesVenture capital funding
00